Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety of Recombinant Hybrid GMZ 2 [GLURP + MSP 3] Blood Stage Malaria Vaccine

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified April 2008 by African Malaria Network Trust.
Recruitment status was:  Recruiting
Sponsor:
Information provided by:
African Malaria Network Trust
ClinicalTrials.gov Identifier:
NCT00424944
First received: January 19, 2007
Last updated: April 1, 2008
Last verified: April 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2008
  Estimated Primary Completion Date: July 2008 (Final data collection date for primary outcome measure)